RT Journal Article
SR Electronic
T1 One year of modeling and forecasting COVID-19 transmission to support policymakers in Connecticut
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.12.20126391
DO 10.1101/2020.06.12.20126391
A1 Olga Morozova
A1 Zehang Richard Li
A1 Forrest W. Crawford
YR 2021
UL http://medrxiv.org/content/early/2021/04/23/2020.06.12.20126391.abstract
AB To support public health policymakers in Connecticut, we developed a county-structured compartmental SEIR-type model of SARS-CoV-2 transmission and COVID-19 disease progression. Our goals were to provide projections of infections, hospitalizations, and deaths, as well as estimates of important features of disease transmission, public behavior, healthcare response, and clinical progression of disease. In this paper, we describe a transmission model developed to meet the changing requirements of public health policymakers and officials in Connecticut from March 2020 to February 2021. We outline the model design, implementation and calibration, and describe how projections and estimates were used to support decision-making in Connecticut throughout the first year of the pandemic. We calibrated this model to data on deaths and hospitalizations, developed a novel measure of close interpersonal contact frequency to capture changes in transmission risk over time and used multiple local data sources to infer dynamics of time-varying model inputs. Estimated time-varying epidemiologic features of the COVID-19 epidemic in Connecticut include the effective reproduction number, cumulative incidence of infection, infection hospitalization and fatality ratios, and the case detection ratio. We describe methodology for producing projections of epidemic evolution under uncertain future scenarios, as well as analytical tools for estimating epidemic features that are difficult to measure directly, such as cumulative incidence and the effects of non-pharmaceutical interventions. The approach takes advantage of our unique access to Connecticut public health surveillance and hospital data and our direct connection to state officials and policymakers. We conclude with a discussion of the limitations inherent in predicting uncertain epidemic trajectories and lessons learned from one year of providing COVID-19 projections in Connecticut.Competing Interest StatementFWC is a paid consultant to Whitespace Solutions.Funding StatementThis work was supported by NIH grants NICHD 1DP2HD091799-01, Cooperative Agreement 6NU50CK000524-01 from the Centers for Disease Control and Prevention, funds from the COVID-19 Paycheck Protection Program and Health Care Enhancement Act, and the Pershing Square Foundation. Computing resources at Stony Brook University were funded by National Science Foundation grant # 1531492.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This analysis does not use patient-level data with personal identifiers.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and code used in this analysis are available from https://github.com/fcrawford/covid19_ct.